Is ALMS Worth Buying in 2026?

Alumis Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-14

Here’s whether Alumis Inc. Common Stock (ALMS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); RSI 61 — healthy momentum range; strong 1-year return of +659.4%; rising volume confirms the move (1.40x 30d avg). Concerns: 50-day MA is falling (-2.86% over 10 days); 3-month momentum negative (-7.8%). Currently 21.1% off its 52-week high. Score: +4/7.

Ready to act on this? 📈 Trade on Webull

ALMS is in a confirmed uptrend, trading above both its 50-day ($22.95) and 200-day ($16.23) moving averages. An RSI of 60.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +659.4% compares to +22.9% for SPY (beat the market by 636.6%). The current 21.1% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $75,943 today
vs. S&P 500 (SPY) — same period beat market by 636.6%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($16.23)
Above 50-day MA ($22.95)
RSI(14) neutral zone (30–70) — currently 60.6
Positive return (+659.4%)
!Within 10% of period high (−21.1%)
Period Range $24.15
$2.76 $30.60
RSI (14) 60.6
0 · OversoldOverbought · 100

Key Metrics

Price$24.15
Period Return+659.4%
Period High$30.60
Period Low$2.76
Drawdown−21.1%
MA-50$22.95
MA-200$16.23
RSI (14)60.6
Avg Volume (30d)1.1M
vs. SPYbeat by 636.6%
Return Rank#13 of 1246

Trade ALMS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers